Search - tctmd.com

Presenter: David R. Holmes, Brad Vazales, Louis A. Cannon, Elisabeth Stahle, Marie-Claude Morice, Michael J. Mack, Ted E. Feldman, A. Pieter Kappetein, Antonio Colombo, Keith D. Dawkins, Friedrich W. Mohr, Patrick W. Serruys

January 03, 2012

News Daily News

Higher Intra-aortic Balloon Use Fails to Help in High-Risk PCI

Jason Kahn

December 11, 2011

News Daily News

FFR-Guidance Demonstrates Benefits in Patients with Unstable Angina, NSTEMI

L.A. McKeown

December 08, 2011

News Industry News

Abbott Initiates Clinical Trial to Evaluate the Absorb™ Bioresorbable Vascular Scaffold Compared to a Metallic Drug Eluting Stent

December 07, 2011

News Conference News

Adenosine-Free Pressure Measurement Found Equivalent to FFR

L.A. McKeown

December 01, 2011

News Conference News

Non-Primary PCI Can Be Performed Safely Without On-site Cardiac Surgery

November 14, 2011

News Industry News

Paclitaxel-coated balloon angioplasty demonstrates superior results

November 10, 2011

News Industry News

Clinical trial of a new dual therapy stent establishes non-inferiority compared to paclitaxel-eluting stent

November 10, 2011

Advertisement

Mode of Revascularization Influenced by Angiographer, Hospital ‘Culture’

La OTC Coronaria Dcha. Predice Mortalidad Tras PCI Principal Dcha

Percutaneous AV Shunt May Do More Harm Than Good in Advanced COPD

Registry Characterizes Prevalence, Management of CTOs Found on Diagnostic Cath

Renal Denervation Bonus: Improving LV Function

Role of Staging and Hybrid Procedures in the Patient with Left Main and Multivessel Disease

Integrated Use of IVUS and FFR During Complex Left Main PCI With and Without Multivessel Disease (with Case Vignettes)

The Surgeon Speaks: When I Would Choose Surgery for Left Main Disease: Lessons from SYNTAX at Four Years

The Interventionalist Speaks: When I Would Choose PCI for Left Main Disease: Lessons from SYNTAX at Four Years

Novel Strategies Advance Cell Therapy for Cardiomyopathy

New Revascularization Appropriateness Criteria Feature PCI Upgrades

Expedited Cell Therapy After STEMI Shows Promise

Four-year Follow-up of the SYNTAX Trial: Optimal Revascularization Strategy in Patients with Three-vessel Disease and/or Left Main Disease

Higher Intra-aortic Balloon Use Fails to Help in High-Risk PCI

FFR-Guidance Demonstrates Benefits in Patients with Unstable Angina, NSTEMI

Abbott Initiates Clinical Trial to Evaluate the Absorb™ Bioresorbable Vascular Scaffold Compared to a Metallic Drug Eluting Stent

Adenosine-Free Pressure Measurement Found Equivalent to FFR

Non-Primary PCI Can Be Performed Safely Without On-site Cardiac Surgery

Paclitaxel-coated balloon angioplasty demonstrates superior results

Clinical trial of a new dual therapy stent establishes non-inferiority compared to paclitaxel-eluting stent

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content